VLDLR and atherosclerosis: Interestingly, several of their neighboring genes (LCAT, VLDLR, PLTP, APP) in the modules have driver roles for atherosclerosis (i.e. gene deletion decreases atherosclerosis risk/phenotype)74–77 and thereby could be attractive targets for drug inhibition.